BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32029291)

  • 21. Racial and Ethnic Disparities in Kidney Transplant Access Within a Theoretical Context of Medical Eligibility.
    Ku E; Lee BK; McCulloch CE; Roll GR; Grimes B; Adey D; Johansen KL
    Transplantation; 2020 Jul; 104(7):1437-1444. PubMed ID: 31568216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colon cancer treatment: are there racial disparities in an equal-access healthcare system?
    Gill AA; Enewold L; Zahm SH; Shriver CD; Stojadinovic A; McGlynn KA; Zhu K
    Dis Colon Rectum; 2014 Sep; 57(9):1059-65. PubMed ID: 25101601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health Insurance Coverage and Racial/Ethnic Disparities in US Childhood and Adolescent Cancer Survival.
    Wang X; Brown DS; Cao Y; Ekenga CC; Guo S; Johnson KJ
    J Pediatr; 2023 Jun; 257():113378. PubMed ID: 36889628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Brasky TM; Cohn DE; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel C; Boggess JF; Pearl ML; Ioffe OB; Deng W; Miller DS; Brinton LA
    Int J Cancer; 2018 Mar; 142(6):1102-1115. PubMed ID: 29063589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.
    Kim S; Dolecek TA; Davis FG
    Soc Sci Med; 2010 Jul; 71(2):274-281. PubMed ID: 20483517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparities in disability among non-Hispanic black elders: results from the National Interview Survey 2001-2003.
    Coustasse A; Emmett D; Patel N; Pekar A
    J Hosp Mark Public Relations; 2009; 19(2):101-12. PubMed ID: 19827321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
    Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
    Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic differences account for racial disparity in uterine cancer survival.
    Smotkin D; Nevadunsky NS; Harris K; Einstein MH; Yu Y; Goldberg GL
    Gynecol Oncol; 2012 Dec; 127(3):616-9. PubMed ID: 22940487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial Comparisons in Timeliness of Colon Cancer Treatment in an Equal-Access Health System.
    Eaglehouse YL; Georg MW; Shriver CD; Zhu K
    J Natl Cancer Inst; 2020 Apr; 112(4):410-417. PubMed ID: 31271431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends of uterine carcinosarcoma in the United States.
    Matsuo K; Ross MS; Machida H; Blake EA; Roman LD
    J Gynecol Oncol; 2018 Mar; 29(2):e22. PubMed ID: 29400015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
    Kucera CW; Chappell NP; Tian C; Richardson MT; Tarney CM; Hamilton CA; Chan JK; Kapp DS; Leath CA; Casablanca Y; Rojas C; Sitler CA; Wenzel L; Klopp A; Jones NL; Rocconi RP; Farley JH; O'Connor TD; Shriver CD; Bateman NW; Conrads TP; Phippen NT; Maxwell GL; Darcy KM
    Gynecol Oncol; 2024 May; 184():224-235. PubMed ID: 38340648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
    Ross J; Braswell KV; Madeira da Silva L; Mujica F; Stutsman S; Finan MA; Nicolson W; Harmon MD; Missanelli M; Cohen A; Singh A; Scalici JM; Rocconi RP
    Gynecol Oncol; 2017 May; 145(2):329-333. PubMed ID: 28215839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
    Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
    Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.
    Fedewa SA; Lerro C; Chase D; Ward EM
    Gynecol Oncol; 2011 Jul; 122(1):63-8. PubMed ID: 21463888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nondisparate Survival of Non-Hispanic Black Women With Breast Cancer Despite Less Favorable Pathology: Effect of Access to and Provision of Care Within a Military Health Care System.
    Darmon S; Lovejoy LA; Shriver CD; Zhu K; Ellsworth RE
    Health Equity; 2023; 7(1):178-184. PubMed ID: 36942312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.
    Kitadai R; Nishikawa T; Yoshida H; Mizoguchi C; Yamamoto K; Kato T; Yonemori K
    J Gynecol Oncol; 2024 Mar; 35(2):e11. PubMed ID: 37914528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
    Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
    J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
    Ortiz AP; Engels EA; Nogueras-González GM; Colón-López V; Soto-Salgado M; Vargas A; Machin M; Shiels MS
    Cancer; 2018 Dec; 124(23):4520-4528. PubMed ID: 30345506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
    Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.